Evolution of the 6-minute Walk Test in Patients Treated With ELEXACAFTOR / TEZACAFTOR / IVACAFTOR

Active, not recruitingOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

November 1, 2023

Study Completion Date

November 1, 2024

Conditions
Cystic Fibrosis
Interventions
OTHER

6-minute walk test

"6-minute walk test in a 40-metre corridor. Included patients are used to performing this test, which is part of the standard care performed during patient follow-up, at least once a year.~Parameters collected during the test: distance walked, minimum SpO2, average SpO2, maximum heart rate, average heart rate, average heart rate over the last 2 minutes, dyspnea scale."

Trial Locations (1)

83406

Respiratory diseases department, Renee Sabran Hospital (Hospices civils de Lyon), Giens

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT06184763 - Evolution of the 6-minute Walk Test in Patients Treated With ELEXACAFTOR / TEZACAFTOR / IVACAFTOR | Biotech Hunter | Biotech Hunter